Court Sets November 2024 Trial for Novo Nordisk’s Arkansas 340B Lawsuit

Novo Nordisk logo on building
Novo Nordisk and the Arkansas Insurance Department are at odds over whether a federal district court should intervene in the enforcement of Arkansas' 340B contract pharmacy law.
The trial for drugmaker Novo Nordisk’s legal challenge to Arkansas’ 340B contract pharmacy law will wait a year to commence. [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

3 Things Hospitals and Grantees Need to Know about the Genesis Decision

SPONSORED CONTENT

The much-awaited decision in the Genesis Health Care patient definition case in federal district court in South Carolina provides 340B hospitals and federal grantees welcome re-affirmations of the importance of the vital safety-net care they provide as well as Congress’s intent to support that care through the 340B program. Although the court limited its decision solely to the Genesis health center, and its decision is potentially subject to appeal, the ruling provides a strong indication that future courts reviewing attempts by HRSA to enforce an overly-restrictive “patient definition” could similarly reject the agency’s restrictions.

Here are 3 things hospitals and grantees need to know regarding their 340B programs from the Genesis decision:

1. Hospitals and grantees should revisit their 340B prescription eligibility criteria.

For more than a quarter century, HRSA relied upon informal guidance to interpret the otherwise undefined term “patient” in the 340B statute to restrict prescriptions 340B hospitals and

Read More »

Hospitals to Meet with White House, HHS About 340B Dispute Resolution Process

The White House plans to release a revised administrative dispute resolution process for the 340B program this month.
Hospital groups will meet with federal executive branch officials to discuss coming changes to the 340B program’s administrative dispute resolution [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Improved Non-Profit Hospital Outlook Helped by 340B Payout: Moody’s

Matt Cahil
The 340B program could have a big impact on not-for-profit hospital finances, said Matt Cahill, assistant vice president for Moody’s.
The 2024 outlook for not-for-profit hospital and health systems improved from negative to stable, in part, due to the planned [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Louisiana Provider Group to Intervene in Second 340B Contract Pharmacy Lawsuit

A federal district judge allowed the Louisiana Primary Care Association's to intervene in a second drug industry lawsuit challenging Louisiana's 340B contract pharmacy law.
A Louisiana provider group was allowed to support the state attorney general’s legal defense of Louisiana’s 340B contract pharmacy law [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Hospitals Continue Lobbying Push to Extend Pandemic-Era 340B Eligibility Waiver

Heywood Hospital joined a coalition of 340B hospitals and providers groups that has asked Congress to extend a 340B eligibility exemption waiver.
A growing coalition of 340B hospitals has asked lawmakers to extend 340B program eligibility exemptions first authorized during the COVID-19 [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Novo Nordisk’s 340B Arkansas Lawsuit Reassigned to Judge Who Previously Ruled Against Drugmakers

Novo Nordisk logo on building
Novo Nordisk and the Arkansas Insurance Department are at odds over whether a federal district court should intervene in the enforcement of Arkansas' 340B contract pharmacy law.
A federal district court transferred drugmaker Novo Nordisk’s lawsuit challenging Arkansas’ 340B contract pharmacy law to a judge who previously [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Louisiana Provider Group to Intervene in 340B Contract Pharmacy Lawsuit

A federal district judge allowed the Louisiana Primary Care Association's to intervene in a second drug industry lawsuit challenging Louisiana's 340B contract pharmacy law.
A federal judge allowed a Louisiana provider group to join the state attorney general in defending Louisiana’s 340B contract pharmacy [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

340B Hospitals Charge Higher Commercial Insurance Prices, Says PhRMA Funded Report

Neil Masia
Neil Masia, Ph.D., authored a Health Capital Group report that found 340B hospitals charge higher commercial insurance prices than non-340B hospitals.
The average hospital in the 340B program charges commercial insurers more than non-340B hospitals, according to a new report, which [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Senate Committee Doubles Down on PBM Bill with 340B Spread Pricing Language

Sen. Ron Wyden (D-Ore.), chairman of the Senate Finance Committee, announced a Dec. 5 hearing on prescription drug shortages that will include testimony from two witnesses who have published research on the 340B program.
Members of the Senate Finance Committee yesterday reiterated support for a pharmacy benefit manager (PBM) transparency bill with 340B spread [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×

*Sign up for news summaries and alerts from 340B Report